HIBERGENE DIAGNOSTICS
Hibergene Diagnostics is a Dublin-based, private Irish company, that develops, manufactures and markets molecular diagnostic tests for human infectious diseases, using the LAMP (Loop Mediated Isothermal Amplification) technology. The company has a growing portfolio of tests, with tests for Meningococcus and Group B Streptococcus already available. In addition, Hibergene has an active research pipeline from which the company expects to release a number of tests on a yearly basis. The tests meet... a significant unmet clinical need allowing clinicians to rapidly, accurately and easily detect human infectious diseases in a near patient setting. The company CEO is Brendan Farrell, an industry veteran, who was a founder of Trinity Biotech. The company is headquartered in Ireland and its investors include a number of institutions and private investors.
HIBERGENE DIAGNOSTICS
Industry:
Biotechnology Health Diagnostics Manufacturing Medical
Founded:
2009-01-01
Address:
Sandyford, Dublin, Ireland
Country:
Ireland
Website Url:
http://www.hibergene.com
Total Employee:
1+
Status:
Active
Contact:
+35319053160
Email Addresses:
[email protected]
Total Funding:
10.34 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Advanced Cell Diagnostics
Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.
Metabolomic Diagnostics
Metabolomic Diagnostics specializes in the development of novel biomarker based diagnostic solutions for complex diseases
Omega Diagnostics - Infectious Disease (ID) business
Omega Diagnostics - Infectious Disease (ID) business specialise in the diagnosis of infectious diseases.
Current Employees Featured
Founder
Investors List
Michael Bristow
Michael Bristow investment in Series B - HiberGene Diagnostics
Kernel Capital
Kernel Capital investment in Series B - HiberGene Diagnostics
Medcaptain
Medcaptain investment in Series B - HiberGene Diagnostics
Cantor Fitzgerald
Cantor Fitzgerald investment in Series B - HiberGene Diagnostics
EASME - EU Executive Agency for SMEs
EASME - EU Executive Agency for SMEs investment in Grant - HiberGene Diagnostics
Kernel Capital
Kernel Capital investment in Series A - HiberGene Diagnostics
More informations about "HiberGene Diagnostics"
HiberGene Diagnostics - Crunchbase Company Profile …
Organization. HiberGene Diagnostics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Hibergene Diagnostics is a Dublin-based, private Irish company, that …See details»
HiberGene Company Profile 2024: Valuation, Funding & Investors
HiberGene General Information Description. Developer of real-time molecular diagnostic tests designed to test for the direct detection of human infectious diseases. The company's tests …See details»
HiberGene Diagnostics - Practical Patient Care
Infectious diseases require fast action if patients are to be treated effectively, contagion contained and lives saved, but current test methods for a number of diseases are slow and insensitive. …See details»
Hibergene Diagnostics collapse now under investigation by …
Oct 22, 2023 The collapse of Hibergene Diagnostics – a former rising star of the Irish healthtech sector – is now under investigation by the Corporate Enforcement Authority, the firm’s …See details»
HiberGene Diagnostics - Craft
It offers HiberGene Meningitis test and Group B Streptococcus test to detect the presence of meningococcus and pneumococcal meningitis; and HG Meningococcus, a test for a severe …See details»
Hibergene diagnoses the roots causes of success in medtech
Dec 5, 2017 Hibergene has developed a broad array of diagnostic tests and is targeting the global market for molecular diagnostics, which is valued at $5bn a year and is growing at rates …See details»
HiberGene Diagnostics - Contacts, Employees, Board Members
HiberGene Diagnostics develops, manufactures and markets molecular diagnostic tests for human infectious diseases.See details»
Medical diagnostics company HiberGene calls in a liquidator
Sep 1, 2022 HiberGene Diagnostics, which was founded in 2009, brought its first product – a test for meningitis – to market in 2015. It has since developed, manufactured and sold 13 …See details»
Medical diagnostics firm HiberGene prepares for liquidation
Sep 12, 2022 HiberGene’s board of directors first informed shareholders of plans to appoint a liquidator on 26 August, according to an update seen by The Irish Times. In this update, the …See details»
HiberGene Diagnostics - VentureRadar
Hibergene has a growing portfolio of molecular diagnostic products for human infectious diseases. Using the proven LAMP (Loop Mediated Isothermal Amplification) technology, the company …See details»
HiberGene Diagnostics - Updates, News, Events, Signals & Triggers
Oct 22, 2023 Organization. HiberGene Diagnostics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Recent News & Activity. …See details»
Rapid Covid-19 test by Irish group HiberGene gets EU approval
HiberGene Diagnostics, which was founded in 2009, brought its first product – a test for meningitis – to market in 2015. It has since developed and sells 13 molecular tests to identify ...See details»
Irish company working on Covid-19 test gets European Union …
Apr 1, 2020 Dublin-based medtech company Hibergene, which is working on a rapid diagnostic test for Covid-19, has secured funding of €1 million from the European Union for the project.See details»
HiberGene Genetics & Genomics News - GenomeWeb
HiberGene to Launch Three Multiplex Infectious Disease Tests by Year End; Seeks US Partner. Premium. The Dublin-based company also aims to raise up to €5 million this year to support …See details»
HiberGene to Launch Three Multiplex Infectious Disease
May 3, 2018 HiberGene was established in 2009, is privately held, and employs 25 people. The firm's technology is based on research performed at the Royal Victoria Hospital in Belfast that …See details»
HiberGene Outlines Plans for Low-Cost Point-of-Care Molecular ...
Jul 19, 2019 HiberGene was founded in 2009 and currently markets laboratory-based diagnostic tests and instruments that rely on LAMP and proprietary chemistries and methods. To date, …See details»
Coronavirus test fast-tracked by Dublin company Hibergene
Feb 12, 2020 Hibergene, a diagnostics company founded in 2014, said its test will undergo clinical evaluation in China in collaboration with its local distribution partner based in Shenzhen.See details»
HiberGene Diagnostics launches innovative PCR Adapt COVID-19 …
Jan 13, 2022 HiberGene CEO, David Corr remarked “Consistent with HiberGene’s mission to challenge long-turnaround times for patient testing, the PCR Adapt COVID-19 test is a high …See details»
HiberGene Molecular SARS-CoV-2 Test Gets CE Mark - GenomeWeb
May 21, 2020 Positive test results can be achieved within 30 minutes on average, HiberGene said, while negative results take about 60 minutes. The CE mark follows the completion of a …See details»
HiberGene Covid-19 test significant in speed and reliability
May 20, 2020 HiberGene’s Covid-19 test is for use when the disease is becoming infective and involves broadly similar proven technology and reagent it has deployed in its tests for …See details»